<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
-------------------------------------------------------
Date of Report: October 25, 1999
(Date of earliest event reported)
Commission File Number 333-33121
LEINER HEALTH PRODUCTS INC.
(Exact name of registrant as specified in its charter)
-------------------------------------------------------
DELAWARE 95-3431709
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
901 East 233rd Street, Carson, California 90745
(310) 835-8400
(Address and telephone number of principal executive offices)
-------------------------------------------------------
1
<PAGE>
Item 5. Other Events
The information set forth in the press release issued by Leiner Health
Products Inc. on October 25, 1999, attached hereto as Exhibit 99.1, is
incorporated herein by reference.
Item 7. Financial Statements and Exhibits
(c) Exhibits
99.1 Press release, dated October 25, 1999
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
LEINER HEALTH PRODUCTS INC.
By: /s/ MICHAEL S. YUSKO
---------------------------
Michael S. Yusko
Vice President and
Chief Financial Officer
Date: October 25, 1999
2
<PAGE>
Exhibit 99.1
For further information:
Gale K. Bensussen
Leiner Health Products
310/835-8400
LEINER HEALTH PRODUCTS ENTERS INTO
AGREEMENT WITH CANADA'S NOVOPHARM
Leiner Plans To Acquire Novopharm's Stanley Pharmaceuticals And Granutec, Inc.
----------------------------------------------------------
Carson, Calif., October 25, 1999 - Leiner Health Products Inc. announced
today that it reached a definitive agreement with Novopharm Limited of
Ontario, Canada to purchase substantially all of the assets of two of its
divisions, Stanley Pharmaceuticals Ltd. and Granutec, Inc., and certain
related assets of Novopharm.
The agreement is subject to various conditions including regulatory
approvals. Details of the transaction have not been announced; however,
closing is currently scheduled to occur prior to the end of December 1999.
Granutec, Inc. is a manufacturer and distributor of
private label, over-the-counter products in the United States. Stanley
Pharmaceuticals Ltd. is a manufacturer and distributor of private label
over-the-counter drugs and vitamin supplements in Canada.
As Canada's leading manufacturer of branded generic drugs with a
line of over 380 products, Novopharm manufactures more than 4.5 billion
tablets and capsules which are used to fill more than 34 million
prescriptions per year and achieves annual Canadian sales of more than $300
million and global sales approaching $600 million.
Leiner Health Products Inc., headquartered in Carson, Calif., is one
of America's leading vitamin, mineral, nutritional supplement and OTC
pharmaceutical manufacturers. The Company markets more than 500 products
under several brand names, including Your Life -Registered Trademark- and
Pharmacist Formula -Registered Trademark-.
# # #
